Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats

Acta Pharmaceutica

Volumn 60, Issue 2, 2010, Pages 129-140

  Batool, Farhat ^a   Hasnat, Ambreen ^a   Haleem, Muhammad ^b   Haleem, Darakhshan ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b SIR SYED UNIVERSITY OF ENGINEERING AND TECHNOLOGY   (Pakistan)

Author keywords

atypical antipsychotics; extrapyramidal side effects; schizophrenia

Indexed keywords

CLOZAPINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; RISPERIDONE; SEROTONIN; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG EFFECT; ELECTROCHEMICAL DETECTION; EXTRAPYRAMIDAL SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; NONHUMAN; RAT; SEROTONIN METABOLISM;

EID: 78650160677     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v1007-010-0014-y     Document Type: Article

References (25)

1. S. Miyamoto, G. E. Duncan, C. E. Marx, J. A. Lieberman Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol. Psychia-try 10 (2005) 79-104 DOI: 10.1038/sj.mp. 4001556. (Pubitemid 40139590)
2. S. Natesan, G. E. Reckless, K. B. Barlow, J. N. Nobrega and S. Kapur, Amisulpride the 'atypical' atypical antipsychotic-comparison to haloperidol, risperidone and clozapine, Schizophr. Res. 105 (2008) 224-235; DOI: 10.1016/j.schres.2008.07.005.
3. 3 dopamine receptors by typical antipsychotic drugs. [123I] epidepride single photon emission tomography (SPET) study, Brit. J. Psychiat. 175 (1999) 231-238; DOI: 10.1192/bjp.175.3.231.
4. S. Leucht, C. Corves, D. Arbter, R. R. Engel, C. Li and J. M. Davis, Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis, Lancet 373 (2009) 31-41; DOI: 10.1016/S0140-6736(08)61764-X.
5. 2 receptor occu-pancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats, Psychopharmacology 150 (2000) 422-429; DOI: 10.1007/s002130000466. (Pubitemid 30470221)
6. J. T. Trevitt, M. Lyons, J. Aberman, D. Carriero, M. Finn and J. D. Salamone, Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function, Psychopharmacology 132 (1997) 74-81; DOI: 10.1007/s002130050322. (Pubitemid 27303742)
7. 2 receptor explain the ac-tion of atypical antipsychotics?: A new hypothesis, Am. J. Psychiat. 158 (2000) 360-369; DOI: 10.1176/appi.ajp.158.3. 360.
8. 1A receptors, Neuropharmacology 35 (1996) 119-121; DOI: 10.1016/0028-3908 (95)00170-0.
9. S. Szymanski, J. Lieberman, S. Pollack, R. Munne, A. Safferman, J. Kane, M. Kronig and T. Coo-per, The dopamine-serotonin relationship in clozapine response, Psychopharmacology 112 (1993) S85-S89; DOI: 10.1007/BF02245011.
10. M. Campbell, P. I. Young, D. N. Bateman, J. M. Smith and S. H. Thomas, The use of atypical antipsychotics in the management of schizophrenia, Br. J. Clin. Pharmaco. 47 (1999) 13-22; DOI: 10.1046/j.1365-2125.1999.00849.x. (Pubitemid 29043159)
11. R. Kumar, G. Palit and B. N. Dhawan, Comparative behavioral effects of typical and atypical antipsychotic drugs in rhesus monkey, Eur. J. Pharmacol. 462 (2003) 133-138; DOI: 10.1016/S0014-2999(02)02957-6. (Pubitemid 36183744)
12. 3 receptor occupancy by risperidone: a [123I]-epidepride SPET study, J. Clin. Psychopharm. 23 (2003) 5-14; DOI: 10.1097/00004714-200302000-00002. (Pubitemid 36164419)
13. D. J. Haleem, F. Batool, N. H. Khan, N. Kamil, O. Ali, Z. S. Saify and M. A. Haleem, Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats, Med. Sci. Monit. 8 (2002) 354-361.
14. F. Batool, S. Ahmed and D. J. Haleem, Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cor-tex, J. Coll. Physicians Surg. Pak. 9 (2009) 139-145.
15. D. J. Haleem, Z. S. Saify, S. Siddiqui, F. Batool and M. A. Haleem, Pre-and postsynaptic re-sponses to 1-(1-naphthylpiperazine) following adaptation to stress in rats, Prog. Neuro-Psychoph. 26 (2002) 149-56; DOI: 10.1016/S0278-5846(01)00240-8. (Pubitemid 34045162)
16. 2 dopa-mine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerized tomography study, Brit. J. Psychiat. 164 (1994) 16-26; DOI: 10.1192/bjp.164.1.16.
17. Q. C. Meng, Y. F. Chen and S. Oparil, A simple method for concentration of biogenic amines and their metabolites from biological samples for analysis by HPLC-EC, Life Sci. 44 (1989) 1207-1213; DOI: 10.1016/0024-3205(89)90316-0. (Pubitemid 19152011)
18. N. Samad, F. Batool and D. J. Haleem, Neurochemical and behavioral effects of 8-OH-DPAT fol-lowing exposure to restraint stress in rats, Pharmacol. Rep. 59 (2007) 173-180.
19. J. de Jong, U. R. Tjaden, E. Visser and W. H. Meijer, Determination of serotonin and 5-hydroxy-indoleacetic acid in urine by reversed-phase ion-pair partition chromatography with fluorime-tric detection, J. Chromatogr. 7 (1987) 85-94.
20. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects, Arch. Gen. Psychiat. 49 (1992) 538-544; DOI: 10.1016/0024-3205(78)90035-8.
21. T. J. Crow, E. C. Johnstone, A. J. Longden and F. Owen, Dopaminergic mechanisms in schizo-phrenia: the antipsychotic effect and the disease process, Life Sci. 23 (1978) 563-567; DOI: 10.1016/0024-3205(78)90035-8. (Pubitemid 9011458)
22. 2 dopamine receptor occu-pancy in clozapine-treated patients, Am. J. Psychiat. 153 (1996) 1571-1578.
23. H. Y. Meltzer and M. Huang, In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems, Prog. Brain Res. 172 (2008) 177-197; DOI: 10.1016/S0079-6123(08)00909-6.
24. 2 dopamine receptor blockade with haloperidol or new anti-psychotic drugs in patients with schizophrenia, Brit. J. Psychiat. 179 (2001) 503-508; DOI: 10.1192/bjp.179.6.503. (Pubitemid 34031674)
25. 2 dopamine receptor occupancy in the living human brain. A PET study with risperidone, Psychopharmacology 110 (1993) 265-272; DOI: 10.1007/BF02251280. (Pubitemid 23051126)